Ube2ctm1.1(KOMP)Wtsi
Targeted Allele Detail
|
|
| Symbol: |
Ube2ctm1.1(KOMP)Wtsi |
| Name: |
ubiquitin-conjugating enzyme E2C; targeted mutation 1.1, Wellcome Trust Sanger Institute |
| MGI ID: |
MGI:5490487 |
| Gene: |
Ube2c Location: Chr2:164611849-164614822 bp, + strand Genetic Position: Chr2, 85.27 cM
|
| Alliance: |
Ube2ctm1.1(KOMP)Wtsi page
|
| IMPC: |
Ube2c gene page |
|
| Mutant Cell Line: |
EPD0411_3_B02 |
| Germline Transmission: |
Earliest citation of germline transmission:
J:188991
|
| Parent Cell Line: |
JM8A3.N1 (ES Cell)
|
| Strain of Origin: |
C57BL/6N-Atm1Brd
|
| Project Collection: |
KOMP-CSD
|
|
| Allele Type: |
|
Targeted (Null/knockout, Reporter) |
| Mutations: |
|
Insertion, Intragenic deletion
Vector: L1L2_Bact_P
|
| |
|
Mutation details: The insertion of the L1L2_Bact_P cassette created a deletion of size 1935 starting at position 164612282 and ending at position 164614217 of Chromosome 2 (Genome Build GRCm39). This deletion results in the removal of functionally critical exon(s). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site was followed by a neomycin selection cassette under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site. Expression of cre recombinase excised the neomycin selection cassette.
(J:148605, J:173534, J:188991)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
|
|
|
| Original: |
J:188991 The Jackson Laboratory, Alleles produced for the KOMP project by The Jackson Laboratory. MGI Direct Data Submission. 2012; |
| All: |
7 reference(s) |
|